+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Insulin-like growth factor 1 (IGF-1), a nutritional marker in patients with eating disorders



Insulin-like growth factor 1 (IGF-1), a nutritional marker in patients with eating disorders



Clinical Nutrition 20(3): 251-257



Though low levels of insulin-like growth factor-1 (IGF-1) have been repeatedly reported in patients with eating disorders, the nutritional significance of IGF-1 has not been evaluated. The study aimed to assess the utility of IGF-1 for screening malnutrition and for monitoring nutrition intervention in patients with eating disorders. IGF-1 and nutritional status were evaluated in 82 patients, 59 with anorexia nervosa (AN), and 23 with bulimia nervosa (BN). Nutritional assessment included the evaluation of body mass index (BMI), body fat (FAT) and muscle mass (MM), assessed by skinfold anthropometry, serum albumin, transthyretin and retinol-binding protein, energy and protein intake. IGF-1 and nutritional parameters were reevaluated in the early phase of refeeding (2-4 weeks) in 20 AN patients who entered a refeeding program. Mean IGF-1 z-score was -1.74+/-0.74 in AN, and -0.74+/-0.91 in BN. Serum proteins were reduced in only a minority of patients. IGF-1 correlated with BMI (r=0.64), FAT (r=0.57), MAMC (mid-arm muscle circumference) (r=0.58) and MM (r=0.66) (P<0.001), while it did not correlate with serum proteins. In the early phase of nutritional repletion serum proteins and anthropometric parameters did not vary significantly, while a prompt and marked increase (73.9%) of IGF-1 was observed. IGF-1 represents a biochemical marker of malnutrition and a sensitive index of nutritional repletion in patients with eating disorders.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 003480062

Download citation: RISBibTeXText

PMID: 11407872

DOI: 10.1054/clnu.2001.0397


Related references

Insulin-like growth factor 1 , a nutritional marker in patients with eating disorders. Clinical Nutrition (Edinburgh) 19(Supplement 1): 4, August, 2000

Insulin-like growth factor I as a marker of nutritional status in patients on enteral nutrition. Nutricion Hospitalaria 9(1): 36-43, 1994

Insulin-like growth factor-binding protein-2 levels in pediatric patients with growth hormone deficiency, eating disorders and acute lymphoblastic leukemia. Hormone Research 53(5): 221-227, 2001

The ratio of insulin-like growth factor-I/insulin-like growth factor-binding protein-3 in sera of patients with hepatitis C virus-related chronic liver disease as a predictive marker of insulin resistance. Nutrition Research 33(1): 27-33, 2013

Insulin-Like Growth Factor-I is a Marker for the Nutritional State. Pediatric Endocrinology Reviews 13(2): 499-511, 2016

Disturbances in the growth hormone-insulin-like growth factor axis in children and adolescents with different eating disorders. Hormone Research 48 Suppl 4: 16-18, 1997

Evaluation of somatomedin 1-C/insulin like growth factor as a nutritional marker in low-birth-weight infants. Clinical Research 41(4): 755A, 1993

Decreased serum insulin-like growth factor-I in burn patients: relationship with serum insulin-like growth factor binding protein-3 proteolysis and the influence of lipid composition in nutritional support. Critical Care Medicine 28(7): 2366-2372, 2000

Insulin-like growth factor-1 as an indicator of nutrition during treatment of adolescent girls with eating disorders. Acta Paediatrica 96(8): 1203-1208, 2007

The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa. Metabolism: Clinical and Experimental 41(1): 106-112, 1992

Plasma insulin-like growth factor I in severely handicapped children: usefulness of insulin-like growth factor I in nutritional assessment and dynamics of growth hormone secretion. No to Hattatsu 24(3): 228-233, 1992

Insulin-like growth factor binding proteins , the growth hormone Insulin-like growth factor-1 axis, age and nutritional indices in cirrhosis. Hepatology 18(4 PART 2): 267A, 1993

Identification of insulin-like growth factor binding protein-2 as a biochemical surrogate marker for the in vivo effects of recombinant human insulin-like growth factor-1 in mice. Journal of Pharmacology and Experimental Therapeutics 281(1): 522-530, 1997

A high ratio of insulin-like growth factor II/insulin-like growth factor binding protein 2 messenger RNA as a marker for anaplasia in meningiomas. Cancer Research 57(13): 2611-2614, 1997

Use of serum insulin-like growth factor and insulin-like growth factor binding proteins levels as a tumor marker in prostate cancer. Clinical Chemistry 45(6 PART 2): A114, June, 1999